Quick Answer
Viatris Inc reported R&D Expense of $751.10 million for fiscal year 2021.
Viatris Inc R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2021 | $751.10M | +35.3% |
| 2020 | $555.10M | -13.3% |
| 2019 | $639.90M | -9.2% |
| 2018 | $704.50M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $250.40M | +26.2% | +14.4% |
| June 30, 2025 | $218.80M | +7.2% | -1.4% |
| March 31, 2025 | $222.00M | +11.2% | +11.9% |
| September 30, 2024 | $198.40M | -6.1% | -2.8% |
| June 30, 2024 | $204.10M | -2.0% | +2.2% |
| March 31, 2024 | $199.70M | +9.2% | -5.4% |
| September 30, 2023 | $211.20M | +20.8% | +1.4% |
| June 30, 2023 | $208.30M | +28.1% | +13.9% |
- Viatris Inc showed an increase of +35.3% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2021 period, Viatris Inc’s r&d expense has grown by 6.6% (from $704.50 million to $751.10 million).
- The most recent figure is from Viatris Inc’s fiscal year 2021 report (Form 10-K), filed with the SEC on February 28, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: